1 Answers

This is a soluble insulin product consisting of the basal insulin degludec and the rapid-acting prandial insulin aspart.

This is to be dosed in accordance with the individual patient's needs. Dose-adjustments are recommended to be primarily based on fasting plasma glucose measurements.

Patients with type 2 diabetes mellitus: The recommended total daily starting dose is 10 units with meal(s) followed by individual dosage adjustments.

Patients with type 1 diabetes mellitus: The recommended starting dose is 600% of the total daily insulin requirements. This is to be used once-daily at meal-time in combination.

This can be administered once- or twice-daily with the main meal(s). When needed, the patient can change the time of administration as long as this insulin is dosed with the largest meal when taken once daily.

In patients with type 2 diabetes mellitus this insulin can be administered alone, in combination with oral anti-diabetic medicinal products, and in combination with bolus insulin.

In type 1 diabetes mellitus, this insulin is combined with short-/rapid-acting insulin at the remaining meals.

Renal and hepatic impairment: This insulin can be used in renal and hepatic impaired patients. Glucose-monitoring is to be intensified and the insulin dose adjusted on an individual basis.

 

ট্রেসিবা ফ্লেক্সটাচ এসসি ইনজেকশন সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে ট্রেসিবা ফ্লেক্সটাচ

1606 views